$9.12
-0.44[-4.60%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$9.12
0[0.00%]
| Open9.570 | Close9.120 |
| Vol / Avg.138.992K / 207.513K | Mkt Cap313.760M |
| Day Range9.080 - 9.570 | 52 Wk Range4.120 - 15.090 |
KalVista Pharma Stock (NASDAQ:KALV), Key Statistics
KalVista Pharma Stock (NASDAQ: KALV) analysis, key statistics.
Valuation Measures
Enterprise Value
213.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.36
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.05
Tangible Book value per share
4.05
Total Liabilities (Quarterly)
21M
Total Assets
160.3M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
KalVista Pharma Stock (NASDAQ:KALV), Key Statistics
KalVista Pharma Stock (NASDAQ: KALV) analysis, key statistics.
Valuation Measures
Enterprise Value
213.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.36
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.05
Tangible Book value per share
4.05
Total Liabilities (Quarterly)
21M
Total Assets
160.3M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
KalVista Pharma Stock (NASDAQ:KALV), Key Statistics
KalVista Pharma Stock (NASDAQ: KALV) analysis, key statistics.
Valuation Measures
Enterprise Value
213.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.36
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.05
Tangible Book value per share
4.05
Total Liabilities (Quarterly)
21M
Total Assets
160.3M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
KalVista Pharma Stock (NASDAQ:KALV), Key Statistics
KalVista Pharma Stock (NASDAQ: KALV) analysis, key statistics.
Valuation Measures
Enterprise Value
213.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.36
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.05
Tangible Book value per share
4.05
Total Liabilities (Quarterly)
21M
Total Assets
160.3M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
KalVista Pharma Stock (NASDAQ:KALV), Key Statistics
KalVista Pharma Stock (NASDAQ: KALV) analysis, key statistics.
Valuation Measures
Enterprise Value
213.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.36
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.05
Tangible Book value per share
4.05
Total Liabilities (Quarterly)
21M
Total Assets
160.3M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
KalVista Pharma Stock (NASDAQ:KALV), Key Statistics
KalVista Pharma Stock (NASDAQ: KALV) analysis, key statistics.
Valuation Measures
Enterprise Value
213.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.36
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.05
Tangible Book value per share
4.05
Total Liabilities (Quarterly)
21M
Total Assets
160.3M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
KalVista Pharma Stock (NASDAQ:KALV), Key Statistics
KalVista Pharma Stock (NASDAQ: KALV) analysis, key statistics.
Valuation Measures
Enterprise Value
213.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.36
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.05
Tangible Book value per share
4.05
Total Liabilities (Quarterly)
21M
Total Assets
160.3M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
KalVista Pharma Stock (NASDAQ:KALV), Key Statistics
KalVista Pharma Stock (NASDAQ: KALV) analysis, key statistics.
Valuation Measures
Enterprise Value
213.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.36
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.05
Tangible Book value per share
4.05
Total Liabilities (Quarterly)
21M
Total Assets
160.3M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
KalVista Pharma Stock (NASDAQ:KALV), Key Statistics
KalVista Pharma Stock (NASDAQ: KALV) analysis, key statistics.
Valuation Measures
Enterprise Value
213.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.36
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.05
Tangible Book value per share
4.05
Total Liabilities (Quarterly)
21M
Total Assets
160.3M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -